91 related articles for article (PubMed ID: 2085240)
1. [Automatization of the immuno-apheresis of hypercholesterolemic plasma in extracorporeal circulation].
Michaely JP; Didelon J; Siadat M; Rivat C; Regnault V; Schooneman F; Stoltz JF
Ann Med Interne (Paris); 1990; 141(7):608-10. PubMed ID: 2085240
[No Abstract] [Full Text] [Related]
2. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
Pusl T; Broedl UC; Parhofer KG; Otto C
Clin Hemorheol Microcirc; 2009; 41(2):137-42. PubMed ID: 19252236
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
5. Is lipoprotein (a)-apheresis useful?
Bambauer R
Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
[TBL] [Abstract][Full Text] [Related]
6. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
Igarashi K; Tsuji M; Nishimura M; Horimoto M
J Clin Apher; 2004; 19(1):11-6. PubMed ID: 15095396
[TBL] [Abstract][Full Text] [Related]
7. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
9. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP).
Lees RS; Holmes NN; Stadler RW; Ibrahim SF; Lees AM
J Clin Apher; 1996; 11(3):132-7. PubMed ID: 8915817
[TBL] [Abstract][Full Text] [Related]
11. [Clinical use of IM-PH immuno-columns].
Maresca MC; Da Porto A; Cusumano S; Serena M
Ann Med Interne (Paris); 1988; 139 Suppl 1():69-71. PubMed ID: 2854714
[TBL] [Abstract][Full Text] [Related]
12. Application of an automated plasma filtration device and a blood monitoring system for LDL apheresis.
Taborski U; Köhler T; Schüpphaus S; Hofmann MR; Müller-Berghaus G
Infusionsther Transfusionsmed; 1992 Aug; 19(4):187-9. PubMed ID: 1422076
[TBL] [Abstract][Full Text] [Related]
13. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
15. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
16. [Lipoprotein plasmapheresis].
Busnach G
Cardiologia; 1998 Sep; 43(9):971-4. PubMed ID: 9859613
[No Abstract] [Full Text] [Related]
17. [Clinical long-term results of H.E.L.P.-apheresis].
Schuff-Werner P
Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
[TBL] [Abstract][Full Text] [Related]
18. [Maximal therapy of hypercholesterolemia in coronary heart disease].
Thiery J; Armstrong V; Bosch T; Eisenhauer T; Schuff-Werner P; Seidel D
Ther Umsch; 1990 Jun; 47(6):520-9. PubMed ID: 2375008
[TBL] [Abstract][Full Text] [Related]
19. [An apheresis method in treatment of familial hypercholesterolemia].
Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150
[No Abstract] [Full Text] [Related]
20. [Indication of treatments based on extracorporeal elimination of cholesterol].
Teruel JL; Lasunción MA
Med Clin (Barc); 1992 Oct; 99(11):417-9. PubMed ID: 1469939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
